BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 25770646)

  • 1. Prognostic factors for cases with no extracranial metastasis in whom brain metastasis is detected after resection of non-small cell lung cancer.
    Bae MK; Yu WS; Byun GE; Lee CY; Lee JG; Kim DJ; Chung KY
    Lung Cancer; 2015 May; 88(2):195-200. PubMed ID: 25770646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of subsets of patients with favorable prognosis after recurrence in completely resected non-small cell lung cancer.
    Sonobe M; Yamada T; Sato M; Menju T; Aoyama A; Sato T; Chen F; Omasa M; Bando T; Date H
    Ann Surg Oncol; 2014 Aug; 21(8):2546-54. PubMed ID: 24633668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic factors for survival in patients treated with stereotactic radiosurgery for recurrent brain metastases after prior whole brain radiotherapy.
    Caballero JA; Sneed PK; Lamborn KR; Ma L; Denduluri S; Nakamura JL; Barani IJ; McDermott MW
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):303-9. PubMed ID: 22079723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiosurgery for non-small cell lung carcinoma metastatic to the brain: long-term outcomes and prognostic factors influencing patient survival time and local tumor control.
    Sheehan JP; Sun MH; Kondziolka D; Flickinger J; Lunsford LD
    J Neurosurg; 2002 Dec; 97(6):1276-81. PubMed ID: 12507123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison Between Surgical Resection and Stereotactic Radiosurgery in Patients with a Single Brain Metastasis from Non-Small Cell Lung Cancer.
    Bougie E; Masson-Côté L; Mathieu D
    World Neurosurg; 2015 Jun; 83(6):900-6. PubMed ID: 25659803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factors of postrecurrence survival in completely resected stage I non-small cell lung cancer with distant metastasis.
    Hung JJ; Jeng WJ; Hsu WH; Wu KJ; Chou TY; Hsieh CC; Huang MH; Liu JS; Wu YC
    Thorax; 2010 Mar; 65(3):241-5. PubMed ID: 20335294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stereotactic irradiation of the postoperative resection cavity for brain metastasis: a frameless linear accelerator-based case series and review of the technique.
    Kelly PJ; Lin YB; Yu AY; Alexander BM; Hacker F; Marcus KJ; Weiss SE
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):95-101. PubMed ID: 21168282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multidose stereotactic radiosurgery (9 Gy × 3) of the postoperative resection cavity for treatment of large brain metastases.
    Minniti G; Esposito V; Clarke E; Scaringi C; Lanzetta G; Salvati M; Raco A; Bozzao A; Maurizi Enrici R
    Int J Radiat Oncol Biol Phys; 2013 Jul; 86(4):623-9. PubMed ID: 23683828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postrecurrence survival in patients with stage I non-small cell lung cancer.
    Nakagawa T; Okumura N; Ohata K; Igai H; Matsuoka T; Kameyama K
    Eur J Cardiothorac Surg; 2008 Sep; 34(3):499-504. PubMed ID: 18579404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment outcome for patients with primary nonsmall-cell lung cancer and synchronous brain metastasis.
    Chidel MA; Suh JH; Greskovich JF; Kupelian PA; Barnett GH
    Radiat Oncol Investig; 1999; 7(5):313-9. PubMed ID: 10580901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of brain metastases from non-small cell lung cancer.
    Baykara M; Kurt G; Buyukberber S; Demirci U; Ceviker N; Algin E; Coskun U; Aykol S; Emmez H; Ozet A; Benekli M
    J Cancer Res Ther; 2014; 10(4):915-21. PubMed ID: 25579528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonsmall cell lung cancer presenting with synchronous solitary brain metastasis.
    Hu C; Chang EL; Hassenbusch SJ; Allen PK; Woo SY; Mahajan A; Komaki R; Liao Z
    Cancer; 2006 May; 106(9):1998-2004. PubMed ID: 16572401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Analysis of initial treatment only by linac-based stereotactic radiosurgery for a metastatic brain tumor from non-small cell lung cancer].
    Nagai M; Oguma H; Arai F; Watanabe E; Nakazawa M
    No Shinkei Geka; 2014 Apr; 42(4):327-34. PubMed ID: 24698893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A nomogram to predict brain metastasis as the first relapse in curatively resected non-small cell lung cancer patients.
    Won YW; Joo J; Yun T; Lee GK; Han JY; Kim HT; Lee JS; Kim MS; Lee JM; Lee HS; Zo JI; Kim S
    Lung Cancer; 2015 May; 88(2):201-7. PubMed ID: 25726044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salvage stereotactic radiosurgery for breast cancer brain metastases: outcomes and prognostic factors.
    Kelly PJ; Lin NU; Claus EB; Quant EC; Weiss SE; Alexander BM
    Cancer; 2012 Apr; 118(8):2014-20. PubMed ID: 21918959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognosis of non-small cell lung cancer with synchronous brain metastases treated with gamma knife radiosurgery.
    Kong DS; Lee JI; Nam DH; Park K; Kim JH; Kim JG; Park JO; Park K
    J Korean Med Sci; 2006 Jun; 21(3):527-32. PubMed ID: 16778400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Definitive chemoradiation therapy following surgical resection or radiosurgery plus whole-brain radiation therapy in non-small cell lung cancer patients with synchronous solitary brain metastasis: a curative approach.
    Parlak C; Mertsoylu H; Güler OC; Onal C; Topkan E
    Int J Radiat Oncol Biol Phys; 2014 Mar; 88(4):885-91. PubMed ID: 24495594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salvage radiosurgery for brain metastases: prognostic factors to consider in patient selection.
    Kurtz G; Zadeh G; Gingras-Hill G; Millar BA; Laperriere NJ; Bernstein M; Jiang H; Ménard C; Chung C
    Int J Radiat Oncol Biol Phys; 2014 Jan; 88(1):137-42. PubMed ID: 24331660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Whole brain irradiation for non-small-cell lung cancer with brain metastasis].
    Shi AH; Zhu GY; Yu R; Ma HM; Liu CQ; Su X; Sun Y; Cai Y; Xu XN; Zhang SW; Xu B
    Zhonghua Zhong Liu Za Zhi; 2007 Jul; 29(7):545-8. PubMed ID: 18069640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neoadjuvant chemotherapy with docetaxel-cisplatin in patients with stage III N2 non-small-cell lung cancer.
    Liao WY; Chen JH; Wu M; Shih JY; Chen KY; Ho CC; Yang JC; Yu CJ
    Clin Lung Cancer; 2013 Jul; 14(4):418-24. PubMed ID: 23291258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.